Keynote

How AI Rebuilt Cancer Testing for a Fairer Fight

Web Summit Vancouver 2025 · James Lumsdaine, CEO of Avitia

Avitia is rebuilding cancer testing from the ground up — making it faster, less invasive, and more equitable. At Web Summit Vancouver 2025, CEO James Lumsdaine explained how AI-powered liquid biopsy changes what's possible at the point of care.

About This Keynote

Avitia's platform uses AI to analyze liquid biopsies at the point of care — no centralized lab, no weeks-long wait. James Lumsdaine's Web Summit session explored how this approach can close the gap between diagnosis and treatment, especially for underserved communities.

Man of the World (MOW) led Avitia's brand and go-to-market communications, including the press launch covered by BusinessWire and subsequent media strategy.